37 related articles for article (PubMed ID: 35769021)
21. Pathological features, immunoprofile and mismatch repair protein expression status in uterine endometrioid carcinoma: focus on MELF pattern of myoinvasion.
Santoro A; Angelico G; Inzani F; Spadola S; Arciuolo D; Valente M; Musarra T; Capelli G; Fanfani F; Gallotta V; Scambia G; Zannoni GF
Eur J Surg Oncol; 2021 Feb; 47(2):338-345. PubMed ID: 32788094
[TBL] [Abstract][Full Text] [Related]
22. Microcystic, elongated, and fragmented pattern invasion is mainly associated with isolated tumor cell pattern metastases in International Federation of Gynecology and Obstetrics grade I endometrioid endometrial cancer.
Pelletier MP; Trinh VQ; Stephenson P; Mes-Masson AM; Samouelian V; Provencher DM; Rahimi K
Hum Pathol; 2017 Apr; 62():33-39. PubMed ID: 27864117
[TBL] [Abstract][Full Text] [Related]
23. Microcystic, Elongated, and Fragmented Pattern Invasion in Ovarian Endometrioid Carcinoma: Immunohistochemical Profile and Prognostic Implications.
Goldberg A; Hand L; DeCotiis D; Rosenblum N; Chan J
Int J Gynecol Pathol; 2018 Jan; 37(1):44-51. PubMed ID: 28319570
[TBL] [Abstract][Full Text] [Related]
24. Microcystic, elongated and fragmented (MELF) pattern in endometrial carcinoma: clinicopathologic analysis and prognostic implications.
Song J; Li H; Guo H; Cai Y
Medicine (Baltimore); 2022 Oct; 101(43):e31369. PubMed ID: 36316927
[TBL] [Abstract][Full Text] [Related]
25. [Microcystic, elongated and fragmented invasion pattern in endometrial carcinoma: the clinicopathology analysis].
Zhang XB; Zhao CL; Qi XL; Qin Y; Wang Y; Shen DH
Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):811-815. PubMed ID: 30585018
[No Abstract] [Full Text] [Related]
26. Tumor Budding in Gynecologic Cancer as a Marker for Poor Survival: A Systematic Review and Meta-Analysis of the Perspectives of Epithelial-Mesenchymal Transition.
Ailia MJ; Thakur N; Chong Y; Yim K
Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326582
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathologic association and prognostic impact of microcystic, elongated and fragmented pattern invasion, combined with tumor budding in endometrioid endometrial cancer.
Qi X; Zhu L; Zhang B
J Obstet Gynaecol Res; 2022 Sep; 48(9):2431-2441. PubMed ID: 35769021
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological significance and prognostic value of myoinvasive patterns in endometrial endometrioid carcinoma.
Amălinei C; Aignătoaei AM; Balan RA; Giuşcă SE; Lozneanu L; Avădănei ER; Căruntu ID
Rom J Morphol Embryol; 2018; 59(1):13-22. PubMed ID: 29940607
[TBL] [Abstract][Full Text] [Related]
29. [Metastatic mechanisms of uterine malignancies and therapeutic consequences].
Lax SF; Tamussino KF; Lang PF
Pathologe; 2016 Nov; 37(6):549-556. PubMed ID: 27757531
[TBL] [Abstract][Full Text] [Related]
30. Patterns of Myometrial Invasion in Endometrial Adenocarcinoma with Emphasizing on Microcystic, Elongated and Fragmented (MELF) Glands Pattern: A Narrative Review of the Literature.
Mateva S; Nikolova M; Yordanov A
Diagnostics (Basel); 2021 Sep; 11(9):. PubMed ID: 34574048
[TBL] [Abstract][Full Text] [Related]
31. How to approach the many faces of endometrioid carcinoma.
Malpica A
Mod Pathol; 2016 Jan; 29 Suppl 1():S29-44. PubMed ID: 26715172
[TBL] [Abstract][Full Text] [Related]
32. Tumor progression, metastasis, and modulators of epithelial-mesenchymal transition in endometrioid endometrial carcinoma: an update.
Makker A; Goel MM
Endocr Relat Cancer; 2016 Feb; 23(2):R85-R111. PubMed ID: 26538531
[TBL] [Abstract][Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]